Cancer Immunotherapy Biomarker Core (CIBC) is a new Proteomics service facility at the University of Houston. Based on a non-profit model, we aim to offer various technologies and expertise in OMICs to the biomedical research community, particularly academic laboratories. Our services include, but are not limited to, cutting-edge targeted proteomics that screen 10-21,000 proteins, autoantigen microarrays for autoantibody screening, biomarker detection, etc. Our products and services cover the entire workflow process – from assay consultation with experienced personnel to data analysis and data presentation.